Eurex Clearing receives U.S. regulatory approval
In light of its status as a registered DCO, Eurex Clearing initially will offer proprietary OTC clearing services to clearing members domiciled in the U.S. including their U.S. affiliates. The EurexOTC Clear for IRS offering will be based on a “no action relief” issued by the CFTC which will be effective for an extended period of time. Subsequently, Eurex Clearing will extend its product offering to also include clearing for clients domiciled in the U.S.
“The DCO approval is an important milestone in our strategy to further expand our global distribution. It also underlines Eurex Clearing’s commitment to our customers in the U.S. market,” said Thomas Book, CEO of Eurex Clearing. “We are pleased that the recognition by the CFTC also reconfirms Eurex Clearing’s industry leading position complying with the highest international standards and state-of-the-art risk management.”
Further information
Eurex Clearing is one of the leading central counterparties globally – assuring the safety and integrity of markets while providing innovation in risk management, clearing technology and client asset protection. Eurex Clearing provides fully-automated, straight-through post-trade services for derivatives, equities, bonds and secured funding & financing, as well as industry-leading risk management technologies.
Eurex Clearing serves more than 185 clearing members in 17 countries, managing a collateral pool of around EUR 57 billion and processing gross risks valued approx. EUR 17 trillion every month.
With EurexOTC Clear for IRS, Eurex Clearing offers integrated clearing and collateralization of OTC transactions and exchange-traded derivatives under the umbrella of a single clearing house in a uniform legal framework covering all products. The OTC clearing service sets new standards in security and efficiency and is now expanded in further jurisdictions.
Комментарии